Status:
COMPLETED
EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer Patient
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Collaborating Sponsors:
University of Lorraine
Conditions:
Breast Cancer
Eye Movement Desensitization and Processing
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The study will consist in an adjustment/adaptation of the "standard EMDR protocol" for cancer disease, and most particulary for women who present a breast cancer and during adjuvant therapy. It will a...
Eligibility Criteria
Inclusion
- Being a woman aged of 18 years or more
- Having a primary invasive breast cancer
- Having undergo a mastectomy for a primary invasive breast cancer
- Being able to complete the questionnaires
- Being informed of the study and having signed the informed consent
- Being affiliated to a welfare system
Exclusion
- having contraindications to recieve EMDR psychotherapy (neurologic disorders, dissociatif states, oculomotor issues)
- Having started adjuvant treatments following surgery
- Having metastatic breast cancer
- Presenting physical polypathologies
- Having psychiatric antecedents (included anxiety and depressif disorders - assessed with M.I.N.I. (Sheehan and al., 1997)).
- Having drug or alcohol addiction
- Being placed under the safeguard of justice, guardianship or trusteeship
- Being pregnant or breast-feeding
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03271476
Start Date
September 1 2017
End Date
July 25 2018
Last Update
January 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Metz-Thionville
Metz, France, 57085